Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort

British Journal of General Practice

Volumn 62, Issue 599, 2012, Pages

  Charles, Morten ^a   Simmons, Rebecca K ^b   Williams, Kate M ^c   Roglic, Gojka ^d   Sharp, Stephen J ^b   Kinmonth, Ann Louise ^c   Wareham, Nicholas J ^b   Griffin, Simon J ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cardiovascular diseases, prevention and control; Diabetes mellitus; Equity; Mass screening; Primary care; Risk factors; Socioeconomic factors

Indexed keywords

ADULT; ARTICLE; CALORIC INTAKE; CARDIOVASCULAR RISK; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK REDUCTION; SMOKING CESSATION; UNITED KINGDOM; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

AGED; ANTIHYPERTENSIVE AGENTS; BODY MASS INDEX; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; RISK REDUCTION BEHAVIOR; SINGLE-BLIND METHOD; SMOKING; WAIST CIRCUMFERENCE;

EID: 84862509749     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp12X649070     Document Type: Article

References (46)

1. Borch-Johnsen K, Lauritzen T, Glumer C, Sandbaek A. Screening for type 2 diabetes -should it be now? Diabet Med 2003; 20(3):175-181.
2. Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 2001; 322(7292): 986-988.
3. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359(15):1577-1589.
4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317(7160): 703-713.
5. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355(9200): 253-259.
6. Pi-Sunyer X, Blackburn G, Brancati FL, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007; 30(6): 1374-1383.
7. Lauritzen T, Griffin S, Borch-Johnsen K, et al. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000; 24(suppl):S6-11.
8. Janssen PG, Gorter KJ, Stolk RP, Rutten GE. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screendetected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br J Gen Pract 2009; 59(558): 43-48.
9. Juul L, Sandbaek A, Foldspang A, et al. Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark. Scand J Prim Health Care 2009; 27(4): 223-231.
10. Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991; 337(8754):1387-1393.
11. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: US trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med 2009; 150(8): 505-515.
12. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 2002;7(1): 29-49.
13. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355(8): 763-778.
14. Puhl RM, Heuer CA. The stigma of obesity: a review and update. Obesity (Silver Spring) 2009; 17(5): 941-964.
15. Reid FD, Cook DG, Whincup PH. Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart 2002; 88(1): 15-19.
16. Simpson CR, Hannaford PC, Williams D. Evidence for inequalities in the management of coronary heart disease in Scotland. Heart 2005; 91(5): 630-634.
17. Legato MJ, Gelzer A, Goland R, et al. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 2006; 3(2): 131-158.
18. Tabenkin H, Eaton CB, Roberts MB, et al. Differences in cardiovascular disease risk factor management in primary care by sex of physician and patient. Ann Fam Med 2010; 8(1):25-32.
19. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999; 340(8):618-626.
20. Echouffo-Tcheugui JB, Simmons RK, et al. The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health 2009; 9:136.
21. Sargeant LA, Simmons RK, Barling RS, et al. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study. Diabet Med 2010; 27(9): 995-1003.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications.Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7):539-553.
23. McIntosh A, Hutchinson A, Home PD, et al. Clinical guidelines and evidence review for type 2 diabetes:management of blood glucose. Sheffield: ScHARR, University of Sheffield, 2001.
24. McIntosh A, Hutchinson A, Home PD, et al. Clinical guidelines and evidence for type 2 diabetes:management of blood pressure. Sheffield: ScHARR, University of Sheffield, 2002.
25. McIntosh A, Hutchinson A, Homne PD, et al. Clinical guidelines and evidence for type 2 diabetes: lipids management. Sheffield: ScHARR, University of Sheffield, 2010.
26. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348(5):383-393.
27. Pyorala K, Pedersen TR, Kjekshus J, et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20(4): 614-620.
28. Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361(9374):2005-2016.
29. Home P, Weinman J. Predicting treatment adherence: an overview of theoretical models. In: Myers L, Midence K, (eds.). Adherence to treatment in medical conditions. London: Harwood Academic, 1998: 25-50.
30. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of the EPIC Norfolk Physical Activity Questionnaire. Int J Epidemiol 2002;31(1):168-174.
31. Bingham SA, Gill C, Welch A, et al. Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 1997; 26(Suppl1): S137-S151.
32. Harding AH, Wareham NJ, Bingham SA, et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer-Norfolk prospective study. Arch Intern Med 2008; 168(14): 1493-1499.
33. Glumer C, Yuyun M, Griffin S, et al. What determines the cost-effectiveness of diabetes screening? Diabetologia 2006; 49(7): 1536-1544.
34. Department of Health. Putting prevention first-vascular checks: risk assessment and management. next steps guidance for primary care trusts. London:Department ofHealth, 2009.
35. Andrews RC, Cooper AR, Montgomery AA, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet 2011;378(9786): 129-139.
36. Simmons RK, Coleman RL, Price HC, et al. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC-Norfolk Cohort. Diabetes Care 2009; 32(4): 708-713.
37. Olivarius NF, Beck-Nielsen H, Andreasen AH, et al. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001;323(7319):970-975.
38. Calles-Escandon J, Lovato LC, Simons-Morton DG, et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the ACCORD trial. Diabetes Care 2010; 33(4):721-727.
39. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358(6): 580-591.
40. Griffin SJ, Borch-Johnsen K, Davies MJ, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011; 378(9786): 156-167.
41. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010; 170(17): 1566-1575.
42. Sigal RJ, Kenny GP, Wasserman DH, et al. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association.Diabetes Care 2006; 29(6): 1433-1438.
43. Chen J, Das S, Barlow CE, et al. Fitness, fatness, and systolic blood pressure: data from the Cooper Center Longitudinal Study. Am Heart J 2010; 160(1):166-170.
44. Gouni-Berthold I, Berthold HK, Mantzoros CS, et al. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 2008; 31(7):1389-1391.
45. Kaminsky J, Gadaleta D. A study of discrimination within the medical community as viewed by obese patients. Obes Surg 2002; 12(1): 14-18.
46. Fontaine KR, Faith MS, Allison DB, Cheskin LJ. Body weight and health care among women in the general population. Arch Fam Med 1998; 7(4):381-384.